Related Experiment Videos
Cephalosporins in the treatment of meningitis
1Department of Medicine, College of Physicians and Surgeons of Columbia University, New York.
Abstract:
The synthesis of new cephalosporin antibiotics has provided agents which can effectively be used to treat most of the different forms of meningitis. None of the first generation cephalosporins can be considered acceptable as agents to treat meningitis. Cefuroxime can be used to treat meningitis due to Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis in children. Agents such as cefotaxime and ceftriaxone are appropriate for neonatal meningitis due to Escherichia coli and group B streptococci, but not Listeria monocytogenes. Cefotaxime, ceftriaxone, ceftizoxime and ceftazidime have all proved effective as therapy of meningitis in children and adults when the pathogens are pneumococci, H. influenzae or N. meningitidis, but they have not been shown to yield an improved mortality or lower morbidity in spite of much greater cerebrospinal fluid (CSF) bactericidal titres. Cefotaxime, ceftizoxime, ceftriaxone and ceftazidime have been effective as therapy of meningitis due to E. coli, K. pneumoniae and Proteus species, but failures have occurred with all of the cephalosporins when used to treat meningitis due to Enterobacter spp. and Serratia marcescens. Only ceftazidime yields adequate CSF concentrations to treat meningitis due to Pseudomonas aeruginosa. Overall, the cephalosporins can now be considered a major component of the therapy of acute bacterial meningitis irrespective of the age group to be treated.
Insights
New cephalosporin antibiotics offer effective treatments for most bacterial meningitis forms across age groups. While not all generations are suitable, newer agents show promise against common pathogens like Streptococcus pneumoniae and Haemophilus influenzae.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Meningitis remains a significant cause of morbidity and mortality.
- First-generation cephalosporins are inadequate for meningitis treatment.
- Advances in cephalosporin synthesis have introduced new therapeutic options.
Purpose of the Study:
- To evaluate the efficacy of various cephalosporin antibiotics in treating bacterial meningitis.
- To identify cephalosporins suitable for different age groups and causative pathogens.
- To assess the role of cephalosporins in the overall management of acute bacterial meningitis.
Main Methods:
- Review of clinical data and in vitro studies on cephalosporin activity against meningitis pathogens.
- Analysis of cerebrospinal fluid (CSF) penetration and bactericidal concentrations.
- Comparison of treatment outcomes for different cephalosporins and patient populations.
Main Results:
- Cefuroxime is effective for meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis in children.
- Cefotaxime and ceftriaxone are appropriate for neonatal meningitis (excluding Listeria monocytogenes).
- Ceftazidime provides adequate CSF concentrations for Pseudomonas aeruginosa meningitis.
Conclusions:
- Cephalosporins are now a major component in treating acute bacterial meningitis.
- Specific cephalosporins demonstrate efficacy against a range of common and challenging meningitis pathogens.
- Continued research is needed to optimize cephalosporin use and improve patient outcomes.